Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03454243 · TERMINATED
Trial details
- NCT number
- NCT03454243
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-15
- Primary completion
- 2018-06-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.